Forewarn, Red Violet Company (NASDAQ: RDVT), a leading consumer insight solution provider, announced that it has entered into a partnership agreement with the Central Illinois Board of REALTORS®, to make its cutting-edge risk assessment and customer due diligence technology available to over 500+ REALTOR® members...
KushCo Holdings (OTCQX: KSHB), a leading player in the Cannabis-based ancillary industry, announced its foray into Hemp Trading, with a focus on acting as a bridge between buyers and sellers of Hemp Commodities. The move is an attempt to expand its CBD footprint by facilitating...
Enlivex Therapeutics (NASDAQ: ENLV), a Company focused on developing allogenic therapies for immune system rebalancing, announced positive interim efficacy data from its ongoing Phase Ib clinical trial in patients with severe sepsis. The analysis in based on data collated from 43 patients with severe sepsis,...
Cyclerion Therapeutics (NASDAQ: CYCN), a clinical-stage Company, announced the failure of its drug candidate praliciguat in meeting the primary endpoints in two separate clinical studies, in diabetic nephropathy (DN) and heart failure with preserved ejection fraction (HFpEF). Praliciguat is a soluble guanylate cyclase (sGC) stimulator...
Amyotrophic Lateral Sclerosis (ALS) or Lou Gehrig’s disease is a progressive neurodegenerative disease, characterized by the atrophy of nerve cells in brain and spinal cord, leading to hardening and scarring in the affected region. As the disease progresses, patients gradually lose the functioning of muscles,...
Infinera (NASDAQ: INFN), a leading optical transmission solution provider, announced that its 7300 Multi-haul Transport Platform, mTera Universal Transport Platform, and Transcend software-defined networking (SDN) solution were adapted by Gtd, a Chilean multi-service telecommunications provider with operations in Chile, Colombia, Peru, and Spain. The systems will be used...
Medicinova (NASDAQ: MNOV), a Company developing small molecule therapeutics, has received notice of allowances for grant of new patents for MN-166 (ibudilast) for the treatment of amyotrophic lateral sclerosis (ALS) from the Canadian Intellectual Property Office, in addition to receiving a Notice of Allowance for...
Provention Bio (NASDAQ: PRVB), a clinical-stage biopharmaceutical Company, announced the grant of a PRIority MEdicines (PRIME) designation by the European Medicines Agency (EMA), for PRV-031 (teplizumab), indicated for the prevention or delay of clinical type 1 diabetes (T1D) in individuals at-risk of developing the disease....
The Global legal marijuana market is likely to reach over USD 66.3 billion by the end of 2025, as per a report by Grand View Research, Inc, growing at a CAGR of 23.9%. There is a growing acceptance of the curative effects of cannabis, with...
dynaCERT (OTCQB: DYFSF), a Company dealing in transportable hydrogen generator aftermarket products, announced the signing of a strategic agreement with MOSOLF group of Europe, which includes collaboration for distributing dynaCERT’s HydraGENä Technology products throughout the European Union. MOSOLF will act as the dealer for Germany...
